UNSPSC 51102864: Neomycin/polymyxin b/prednisolone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP350. This VA Drug Class (OP350) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51102864 Neomycin/polymyxin b/prednisolone is a Commodity code that in recent state and local solicitation activity reflects pharmaceutical products supplied through cooperative purchasing agreements and direct health procurement. The code nominally names a specific antibiotic-corticosteroid combination, but recent opportunities show state and local health agencies using similar codes to tag purchases of broader pharmaceutical inventory, including antibiotics, opioid antagonists, and drug deactivation systems sourced through piggyback contracts and competitive bids. Issuing bodies include state health departments and county health and emergency services functions; the Illinois Department of Public Health and Seminole County, Florida both used related pharmaceutical procurement vehicles in 2026.

Recent activity spans Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392, IFB process, $2,999,999.11 over three years) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse consortium, with quarterly supply and 12-month initial term plus two renewal years. Seminole County, Florida issued an IFB (IFB60459723LAS, posted June 30, 2026, due July 26, 2026) for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, requiring vendors to include shipping costs and maintain drug-free workplace and E-Verify compliance. The code shows limited recent activity and inconsistent product alignment; vendors pursuing this code should verify whether the actual solicitation product matches the nominal code description before bid response.